Home Tags Antibody-drug Conjugates

Tag: Antibody-drug Conjugates

YProtech: Specialists in High Value Chemistries, from Early Research and Lead...

Established in 2011 YProtech is a leading Chemistry Services Contract Research Organization specializing in high value chemistry services.The company offers niche chemistry based services...

Simplifying the Development of Site-specific Antibody-drugs Conjugates

Research by Rice University scientists, supported by the National Science Foundation and the Robert A. Welch Foundation, shows the developed a method to efficiently...

Antibody-drug Conjugates: Technologies and Global Markets

Less than 3 decades old, antibody-drug conjugate or ADC-technology is a relatively new.  Due to many technological advances, recognition of appropriate target antigens, success...
Singapore skyline

Critical Aspects of Investigational New Drug (IND) Applications: An Interview with...

EAG Laboratories is a global scientific services company providing testing, analytical and characterization services to clients across a vast array of technology- and life-science-related industries....

Selenomab-drug Conjugates: Delivering Strong Results in Treating Cancers

Scientists from the Florida campus of The Scripps Research Institute (TSRI), one of the world's largest independent, not-for-profit organizations focusing on research in the...

Ambrx and MabSpace Biosciences Jointly Develop New Antibody Drug Conjugates

San Diego based biotech company Ambrx and MabSpace Biosciences, a biotechnology company focusing on discovery and development antibody therapeutics using its immune tolerance breaking...

Improving Outcomes in the Treatment of Breast Cancer (Video)

Over the last 25 years, there has been an explosion of new and vitally important, anticancer drugs.The development of these promising new therapeutic agents...

Global Industry Analysis, Size, Share, Growth, Trends and Forecast

In Late December 2016 Researchmoz added its latest, up-to-date research on antibody-drug conjugates (ADC) to its already large collection of research reports.In the report,...

Study Confirms: ADCs Show Clinical Efficacy with Acceptable Toxicity

In the past 10 - 15 years, Antibody Drug Conjugates or ADCs have shown a clearly documented efficacy and acceptable toxicity and can be easily...

NBE Therapeutics and SOTIO Collaborate in the Development of the Next-Gen...

NBE Therapeutics, a privately owned Swiss, Basel-based Biotech company, and SOTIO, a biotechnology company located in Prague, Czech Republic, with facilities in Europe, the United...